Item 5.07 Submission of Matters to a Vote of Security Holders. OnJune 18, 2020 , bluebird bio, Inc. (the "Company") held its previously announced Annual Meeting of Stockholders (the "Meeting"), at which a quorum was present. At the Meeting, the stockholders of the Company voted on the three proposals as follows: (i)Nick Leschly ,Douglas A. Melton , Ph.D., andMark Vachon as Class I members of the Board to serve until the Company's 2023 annual meeting of stockholders ("Proposal 1"); (ii) to approve, on a non-binding advisory basis, the compensation paid to our named executive officers ("Proposal 2"); and (iii) to ratify the selection ofErnst & Young LLP as the Company's independent registered public accounting firm for the fiscal year endingDecember 31, 2020 ("Proposal 3").
The Company's stockholders re-elected the three persons listed below as Class I directors pursuant to Proposal 1. The voting results were as follows:
Votes For Votes Against Abstentions Broker Non-Votes Nick Leschly 45,322,260 338,436 15,773 4,473,908 Douglas A. Melton, Ph.D. 44,648,050
875,905 152,514 4,473,908 Mark Vachon 45,322,980 335,066 18,423 4,473,908
The Company's stockholders approved Proposal 2 in a non-binding advisory vote. The voting results were as follows:
Votes For Votes Against Abstentions Broker Non-Votes 27,848,106 17,778,200 50,163 4,473,908 The Company's stockholders approved Proposal 3. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 49,523,966 589,361 37,050 0
--------------------------------------------------------------------------------
© Edgar Online, source